Literature DB >> 8143786

Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene.

M Rubini1, H Werner, E Gandini, C T Roberts, D LeRoith, R Baserga.   

Abstract

Stimulation by platelet-derived growth factor (PDGF) is known to increase the number of IGF-I binding sites in cells in culture. We show here that PDGF also increases the levels of IGF-1 receptor mRNA. Using cell lines stably transfected with an expression plasmid in which the reporter luciferase gene is under the control of the rat IGF-1 receptor gene promoter, we find that PDGF increases the activity of this promoter. A short IGF-1 receptor gene promoter, comprising about 100 base pairs of the sequence immediately upstream of the initiation of transcription site, is sufficient for a response to the stimulatory action of PDGF. These results suggest that an increase in RNA levels and in promoter activity may play an important role in the increase in IGF-1 receptor levels that occurs after stimulation by PDGF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143786     DOI: 10.1006/excr.1994.1101

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal.

Authors:  M Prisco; A Hongo; M G Rizzo; A Sacchi; R Baserga
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.

Authors:  H Werner; C T Roberts; F J Rauscher; D LeRoith
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

3.  Growth factors regulate expression of mineral associated genes in cementoblasts.

Authors:  N E Saygin; Y Tokiyasu; W V Giannobile; M J Somerman
Journal:  J Periodontol       Date:  2000-10       Impact factor: 6.993

Review 4.  The roles of growth factors in tendon and ligament healing.

Authors:  Timothy Molloy; Yao Wang; George Murrell
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 5.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

6.  Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.

Authors:  H Werner; Z Shen-Orr; F J Rauscher; J F Morris; C T Roberts; D LeRoith
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

7.  Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes.

Authors:  A Morrione; T DeAngelis; R Baserga
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells.

Authors:  M A Steller; C H Delgado; Z Zou
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

9.  A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor.

Authors:  D Coppola; A Ferber; M Miura; C Sell; C D'Ambrosio; R Rubin; R Baserga
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

10.  Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.

Authors:  F Canzian; J D McKay; R J Cleveland; L Dossus; C Biessy; S Rinaldi; S Landi; C Boillot; S Monnier; V Chajès; F Clavel-Chapelon; B Téhard; J Chang-Claude; J Linseisen; P H Lahmann; T Pischon; D Trichopoulos; A Trichopoulou; D Zilis; D Palli; R Tumino; P Vineis; F Berrino; H B Bueno-de-Mesquita; C H van Gils; P H M Peeters; G Pera; E Ardanaz; M-D Chirlaque; J R Quirós; N Larrañaga; C Martínez-García; N E Allen; T J Key; S A Bingham; K-T Khaw; N Slimani; T Norat; E Riboli; R Kaaks
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.